Literature DB >> 24523839

A urological challenge: Voiding dysfunction in multiple sclerosis.

Jacques Corcos1.   

Abstract

Patients with multiple sclerosis (MS) have a very high prevalence of lower urinary tract symptoms. This summary provides a brief overview of MS epidemiology, pathophysiology, the impact of the disease on patient quality of life, and the particular kinds of urinary tract abnormalities and symptoms that can present among patients with MS. Strategies to help diminish the impact of these symptoms are also discussed.

Entities:  

Year:  2013        PMID： 24523839      PMCID： PMC3919189          DOI： 10.5489/cuaj.1618

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  15 in total

1.  Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia.

Authors:  E J Chartier-Kastler; J L Ruud Bosch; M Perrigot; M B Chancellor; F Richard; P Denys
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

2.  Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system.

Authors:  M Ukkonen; I Elovaara; P Dastidar; T L J Tammela
Journal:  Acta Neurol Scand       Date:  2004-02       Impact factor: 3.209

3.  BLADDER DYSFUNCTION IN MULTIPLE SCLEROSIS.

Authors:  H MILLER; C A SIMPSON; W K YEATES
Journal:  Br Med J       Date:  1965-05-15

4.  Urinary, faecal and sexual dysfunction in patients with multiple sclerosis.

Authors:  A Hennessey; N P Robertson; R Swingler; D A Compston
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

5.  Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.

Authors:  Sender Herschorn; Jerzy Gajewski; Karen Ethans; Jacques Corcos; Kevin Carlson; Gregory Bailly; Robert Bard; Luc Valiquette; Richard Baverstock; Lesley Carr; Sidney Radomski
Journal:  J Urol       Date:  2011-04-16       Impact factor: 7.450

6.  Cystometric and sphincter abnormalities in multiple sclerosis.

Authors:  W E Bradley; J L Logothetis; G W Timm
Journal:  Neurology       Date:  1973-10       Impact factor: 9.910

7.  Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses.

Authors:  Nora Buser; Sandra Ivic; Thomas M Kessler; Alfons G H Kessels; Lucas M Bachmann
Journal:  Eur Urol       Date:  2012-09-07       Impact factor: 20.096

Review 8.  Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis.

Authors:  Oscar Fernández
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

9.  Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis.

Authors:  Shahid Khan; Xavier Game; Vinay Kalsi; Gwen Gonzales; Jalesh Panicker; Sohier Elneil; Apostolos Apostolidis; Rizwan Hamid; Prokar Dasgupta; Thomas M Kessler; Clare J Fowler
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

10.  The cervical cord in multiple sclerosis.

Authors:  D R Oppenheimer
Journal:  Neuropathol Appl Neurobiol       Date:  1978 Mar-Apr       Impact factor: 8.090
View more
  6 in total

1.  Neurogenic Causes of Detrusor Underactivity.

Authors:  Brian T Kadow; Pradeep Tyagi; Christopher J Chermansky
Journal:  Curr Bladder Dysfunct Rep       Date:  2015-09-15

Review 2.  Lower urinary tract dysfunction in common neurological diseases.

Authors:  Mohamad Moussa; Athanasios Papatsoris; Mohamed Abou Chakra; Yousef Fares; Athanasios Dellis
Journal:  Turk J Urol       Date:  2020-04-30

3.  Effects of physiotherapy treatment for urinary incontinence in patient with multiple sclerosis.

Authors:  Carla Maria de Abreu Pereira; Mariane Castiglione; Karina Tamy Kasawara
Journal:  J Phys Ther Sci       Date:  2017-07-15

4.  Data-Driven Machine-Learning Quantifies Differences in the Voiding Initiation Network in Neurogenic Voiding Dysfunction in Women With Multiple Sclerosis.

Authors:  Christof Karmonik; Timothy Boone; Rose Khavari
Journal:  Int Neurourol J       Date:  2019-09-30       Impact factor: 2.835

5.  Physical and Mental Health Comorbidities Among Adults With Multiple Sclerosis.

Authors:  Mark D Peterson; Paul Lin; Neil Kamdar; Christina N Marsack-Topolewski; Elham Mahmoudi
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-12-23

6.  Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis.

Authors:  Hawra B Al Dandan; Susan Coote; Doreen McClurg
Journal:  Int J MS Care       Date:  2020 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.